Clear Search sequence regions


  • 2 methoxyestradiol (4)
  • antitumor agent (1)
  • apoptosis (2)
  • DRP1 (1)
  • female (2)
  • impairs (1)
  • meiosis (1)
  • MFN1 (1)
  • mice (3)
  • oocytes (7)
  • Opa1 (1)
  • ovaries (2)
  • oxygen (1)
  • phenotypes (1)
  • serum (1)
  • species (1)
  • Sizes of these terms reflect their relevance to your search.

    2-Methoxyestradiol (2-ME2) is a metabolite of 17β-estradiol and is currently in clinical trials as an antitumor agent. Here we found 2-ME2 level remains stable in the local environment of ovaries but declines in serum in aging mice, and exogenous 2-ME2 impacts the meiotic maturation of mouse oocytes in dose-dependent manner. In vitro 2-ME2 application arrested oocytes at metaphase I (MI), with abnormal spindle structure and chromosome alignment. 2-ME2 exposure induced excessive production of reactive oxygen species (ROS) and malondialdehyde, as well as accelerated apoptosis progression. 2-ME2 unbalanced mitochondrial dynamics by increasing DRP1 and MFN1 while decreasing Opa1. Similar phenotypes were also observed in oocytes from mice injected intraperitoneally with 2-ME2. Taken together, this study indicates 2-ME2 exposure impairs oocyte meiotic maturation through inducing mitochondrial imbalance, oxidative stress and apoptosis. The gradual decline in oocyte quality and quantity may be associated with the stable 2-ME2 in ovaries during female reproductive aging. Copyright © 2022. Published by Elsevier B.V.

    Citation

    Xiuying Jiang, Xiangning Xu, Bicheng Wang, Ke Song, Jiaqi Zhang, Ye Chen, Ying Tian, Jing Weng, Yuanjing Liang, Wei Ma. Adverse effects of 2-Methoxyestradiol on mouse oocytes during reproductive aging. Chemico-biological interactions. 2023 Jan 05;369:110277

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36414027

    View Full Text